Eti Yoles

Eti Yoles has extensive work experience in the biotechnology industry, beginning in 1993 as a research associate at the Weizmann Institute of Science. In 2002, they became the VP of R&D at Proneuron Biotechnologies, and in 2008 they moved to NeuroQuest as Managing Director. In 2013, they joined ImmunoBrain Therapies, Ltd. as CSO, and in 2016 they became the Chief Operating Officer of ImmunoBrain Checkpoint.

Eti Yoles attended Bar-Ilan University from 1985 to 1990, where they obtained a PhD in Neurophysiology.